Poziom wiedzy na temat profilaktyki przeciwzakrzepowej wśród pacjentów z migotaniem przedsionków

Abstract

Introduction. In modern therapy of patients with atrial fibrillation, which belongs to the group particularly at risk of stroke, prophylactic anticoagulation is of primary importance. The initiation and subsequent proper monitoring of long-term anticoagulation therapy is very important for this group of patients. The use of oral anticoagulants significantly reduces the risk of ischemic stroke, and thus ensures longer survival and avoidance of permanent disability among patients with atrial fibrillation. Aim. Assessment of the level of knowledge of patients with atrial fibrillation on thromboprophylaxis in internal departments and cardiology of the Provin-cial Specialist Hospital in Włocławek. Materials and methods. The study group consisted of 100 people (63 men and 37 women) with diagnosed atrial fibrillation, taking oral anticoagulants. The research tool was the author's questionnaire. To assess the risk of ischem-ic stroke in this group of patients, the CHA2DS2-VASc scale was used and ques-tions about these factors were included in the survey. Results. Studies show that anticoagulant prophylaxis in the form of oral anti-coagulants is used in every patient with diagnosed atrial fibrillation. Most pa-tients use new generation drugs (NOAC) that do not require dose adjustment based on a normalized INR. Persistent atrial fibrillation was found in 51% of the patients. The most numerous group were patients in the 65-74 age range. The annual risk of stroke in my subjects was on average 11%. In most cases, patients correctly answered questions about the rules of conduct when using oral anticoagulants, factors that increase and weaken the effects of these drugs and the symptoms of their overdose. There were no significant differences in the level of knowledge between the women and men studied, while younger, better educated patients who declared a very good or satisfactory material situ-ation showed more knowledge. Conclusions. The study showed that the level of patients' knowledge about antithrombotic prophylaxis in atrial fibrillation is at a good level and corresponds to current medical knowledge.